You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

According to Statifacts, the global clinical trials market size is calculated at USD 126.30 billion in 2025 and is expected ...

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

The company has assembled a team that hails from DeepMind and Microsoft, AI in drug discovery specialist Exscientia, genomics and machine learning company Zymergen (bought by Ginkgo Bioworks in 2022), ...

BOSTON, MA, UNITED STATES, February 13, 2025 /EINPresswire / -- When Ruihua Liu founded Hill Research, the goal was clear: to revolutionize clinical trials using Generative AI. With a background in ...

Former DeepMind employees raise $40 million to launch London-based startup 'laser-focused' on AI protein design.

The Vancouver-based company uses generative AI to create biologic drugs, with 20 “active programs” underway, many of them ...

Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced ...

Axcelis Technologies, Inc. , a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its innovative Puriontm platform of ion ...

The integration of AI in healthcare as a means by which to enhance diagnostic accuracy and treatment planning also appeared ...